{"nct_id":"NCT03328026","title":"Combination Study of SV-BR-1-GM With Retifanlimab","status":"ENROLLING_BY_INVITATION","status_verified_date":"2025-02","start_date":"2018-03-16","start_date_type":"ACTUAL","primary_completion_date":"2025-11-03","primary_completion_date_type":"ESTIMATED","completion_date":"2028-11-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["BCTX"]}